JUNSHI BIO (688180.SH): Shanghai Tan Ying and Shanghai Tan Zheng plan to reduce their holdings of the company's shares by no more than 0.75%.
Junshi Biosciences (688180.SH) announced that Shanghai TanYing and Shanghai TanZheng have a long-term optimistic view on the company's development, because...
JUNSHI BIO (688180.SH) announced that Shanghai Tanying and Shanghai Tanzheng are optimistic about the company's development in the long term. Due to the fund's term and liquidity arrangements, Shanghai Tanying and Shanghai Tanzheng plan to reduce their holdings of the company's shares in a total amount not exceeding 739,270 shares through centralized bidding and bulk trading, with a cumulative reduction ratio not exceeding 0.75% of the total share capital of the company.
Related Articles
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
RECOMMEND
